Muscle aging in older men starting hormone therapy
Part of Brain & nervous system, Cancer, Kidney & urinary clinical trials.
This study looks at how hormone therapy (ADT) affects muscle aging in older men with prostate cancer. It aims to understand why muscles weaken during this treatment, which could lead to better ways to protect muscle health in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years or older.
- You have prostate cancer and are about to start hormone therapy (ADT) for the first time, or have started it within the last 2 weeks.
- You have not had chemotherapy within the past year.
- You have no major surgery planned within the next 6 months.
- If you choose the optional muscle biopsy, you must not be taking certain blood thinners or have a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised exercise program can help men with prostate cancer stay stronger and feel better during combined radiation and hormone therapy. You may be able to join if you are about to start these treatments and are otherwise healthy enough to exercise.
This trial tests whether doing strength training during hormone therapy can help your immune system fight prostate cancer better. It involves supervised exercise sessions alongside your usual treatment.
This study tests whether a supervised exercise program can help manage side effects like fatigue and muscle loss when starting hormone therapy for prostate cancer. Participation may improve your quality of life during treatment.
This trial tests a supervised exercise program to see if it can reduce frailty and muscle loss in men with metastatic prostate cancer who are on hormone therapy. It may help you become stronger and feel better during treatment.
This study tests a combination of two hormone therapies to treat prostate cancer that has spread and to see if it improves outcomes for men who are also frail. It aims to help men who have symptoms of frailty and may not tolerate standard treatments.
This study tests a combined exercise program (aerobic and strength training) for men with prostate cancer who are on hormone therapy. It aims to see if the program helps improve health and well-being during treatment.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.